BSG and colorectal carcinoma: Based on these findings, a noninvasivemethod for detecting CRC by CD147-positive EVs was devised: a quantitativelateral flow immunoassay test that uses magnetic nanoparticles aslabels connected to an inductive sensor.145 Indications from the findings of the CD147 antigen quantificationin EVs extracted from plasma suggest that this device, with its user-friendlydesign and quick reaction time, can be utilized as a point-of-caretool for colorectal cancer screening or treatment monitoring.